A Post-Authorisation Safety Study (PASS) of ABRYSVO (Respiratory Syncytial Virus Stabilised Prefusion Subunit Vaccine) in Pregnant Women and their Offspring in a Real World Setting in Europe and UK (C3671026)

13/01/2025
03/02/2026
EU PAS number:
EUPAS1000000399
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C3671026_RSV VACCINE MATERNAL PROTOCOL_V2.0_06AUG2024.pdf

English (1.83 MB - PDF) View document
Updated protocol

C3671026_PROTOCOL AMENDMENT 2 V4.0_09JAN2026.pdf

First published: 30/01/2026
English (2.32 MB - PDF) View document

C3671026_RSV VACCINE MATERNAL PROTOCOL AMENDMENT 1 V3.0_13NOV2025.pdf

First published: 21/01/2026
English (2.3 MB - PDF) View document
Study results
Study report
Study report

c3671026-pass-progress-report1-report-body.pdf

English (800.29 KB - PDF) View document

C3671026_PROGRESS REPORT 1 UPDATED VERSION 2.0_03SEP2025.pdf

English (270.93 KB - PDF) View document
Other information